HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ephraim J Fuchs Selected Research

Autoimmune Diseases (Autoimmune Disease)

7/2010High-dose, post-transplantation cyclophosphamide to promote graft-host tolerance after allogeneic hematopoietic stem cell transplantation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ephraim J Fuchs Research Topics

Disease

48Graft vs Host Disease (Graft-Versus-Host Disease)
01/2023 - 04/2006
34Hematologic Neoplasms (Hematological Malignancy)
01/2023 - 03/2002
16Neoplasms (Cancer)
10/2022 - 02/2003
11Leukemia
10/2022 - 02/2003
7Sickle Cell Anemia (Hemoglobin S Disease)
04/2019 - 08/2003
5Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2023 - 05/2004
5Lymphoma (Lymphomas)
01/2023 - 10/2007
3Aplastic Anemia (Anemia, Hypoplastic)
01/2023 - 03/2010
3Myelodysplastic Syndromes (Myelodysplastic Syndrome)
10/2022 - 12/2014
3Infections
12/2020 - 12/2015
3Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
10/2020 - 12/2014
3Hodgkin Disease (Hodgkin's Disease)
01/2020 - 11/2008
3Multiple Myeloma
11/2017 - 05/2003
3Bronchiolitis Obliterans Syndrome
01/2017 - 04/2013
2Philadelphia Chromosome
01/2023 - 10/2020
2Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
01/2023 - 04/2013
2Disease Progression
01/2020 - 05/2011
2Fever (Fevers)
12/2019 - 10/2018
2Hemoglobinopathies
01/2018 - 08/2003
2Thalassemia
01/2018 - 08/2003
1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
01/2023
1T-Cell Lymphoma (Lymphoma, T Cell)
01/2023
1Enteropathy-Associated T-Cell Lymphoma
01/2023
1Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
01/2023
1Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
12/2022
1Thrombotic Microangiopathies
12/2020
1Residual Neoplasm
01/2020
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2020
1Cytokine Release Syndrome
12/2019
1Brain Diseases (Brain Disorder)
12/2019
1Prostatic Neoplasms (Prostate Cancer)
01/2018
1Fanconi Anemia (Fanconi's Anemia)
02/2017
1B-Cell Lymphoma (Lymphoma, B Cell)
12/2015
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
10/2013
1Immune System Diseases (Immune Disorders)
12/2012
1Autoimmune Diseases (Autoimmune Disease)
07/2010
1Bone Marrow Failure Disorders
03/2010
1Colonic Neoplasms (Colon Cancer)
08/2009
1Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria)
06/2008

Drug/Important Bio-Agent (IBA)

53Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2023 - 05/2008
6HLA Antigens (Human Leukocyte Antigens)IBA
01/2019 - 04/2010
5Mycophenolic Acid (Cellcept)FDA LinkGeneric
10/2021 - 11/2012
4Calcineurin InhibitorsIBA
10/2021 - 08/2015
4Tacrolimus (Prograf)FDA LinkGeneric
01/2021 - 11/2012
3fludarabineIBA
10/2021 - 11/2012
2trans-crotonin (CTN)IBA
01/2023 - 03/2014
2Cyclosporine (Ciclosporin)FDA LinkGeneric
01/2021 - 10/2007
2Immune Checkpoint InhibitorsIBA
01/2020 - 11/2018
2CytokinesIBA
12/2019 - 10/2007
2LigandsIBA
04/2010 - 02/2006
2Interferon-gamma (Interferon, gamma)IBA
08/2009 - 10/2007
1Anaplastic Lymphoma KinaseIBA
01/2023
1HaptoglobinsIBA
12/2020
1Chimeric Antigen ReceptorsIBA
10/2020
1Immunoconjugates (Immunoconjugate)IBA
10/2020
1Enfuvirtide (Fuzeon)FDA Link
01/2020
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2020
1Busulfan (Busulfex)FDA Link
01/2020
1NivolumabIBA
11/2018
1pembrolizumabIBA
11/2018
1HLA-A Antigens (HLA-A)IBA
10/2018
1HLA-DRB1 Chains (HLA DRB1)IBA
10/2018
1acetyl- 2- naphthylalanyl- 3- chlorophenylalanyl- 1- oxohexadecyl- seryl- 4- aminophenylalanyl(hydroorotyl)- 4- aminophenylalanyl(carbamoyl)- leucyl- ILys- prolyl- alaninamideFDA Link
01/2018
1AndrogensIBA
01/2018
1Hormones (Hormone)IBA
01/2018
1ABO Blood-Group SystemIBA
01/2018
1Blocking AntibodiesIBA
01/2018
1cyclo(Arg-Pro) (CI 4)IBA
11/2017
1Rituximab (Mabthera)FDA Link
12/2015
1A 17 (A-17)IBA
04/2013
1Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA
11/2012
1Sirolimus (Rapamycin)FDA Link
11/2012
1Azacitidine (5 Azacytidine)FDA Link
05/2011
1KIR ReceptorsIBA
04/2010
1Neoplasm Antigens (Tumor Antigens)IBA
08/2009
1Isoantigens (Alloantigen)IBA
05/2008
1Interleukin-2 (IL2)IBA
10/2007
1Caspase 3 (Caspase-3)IBA
02/2006
1Granzymes (Granzyme)IBA
02/2006

Therapy/Procedure

53Transplantation
01/2023 - 03/2002
26Bone Marrow Transplantation (Transplantation, Bone Marrow)
01/2023 - 03/2002
12Therapeutics
01/2023 - 02/2004
7Cell Transplantation
10/2022 - 11/2008
6Drug Therapy (Chemotherapy)
01/2023 - 10/2007
6Haploidentical Transplantation
01/2021 - 01/2012
6Immunotherapy
10/2020 - 02/2003
6Hematopoietic Stem Cell Transplantation
11/2016 - 08/2003
5Stem Cell Transplantation
11/2016 - 02/2003
4Homologous Transplantation
10/2020 - 04/2006
3Cryosurgery
01/2018 - 08/2009
2Donor Selection
04/2016 - 12/2015
2Salvage Therapy
05/2011 - 05/2010
2Cryotherapy (Therapy, Cold)
05/2010 - 08/2009
1Renal Replacement Therapy (Therapies, Renal Replacement)
12/2020
1Art Therapy
01/2020
1Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
12/2019
1Renal Dialysis (Hemodialysis)
12/2019
1Intraperitoneal Injections
01/2018
1Cautery
08/2009
1Autologous Transplantation
10/2007